Advertisement

Current Heart Failure Reports

, Volume 13, Issue 6, pp 302–309 | Cite as

New Challenges in the Treatment of Patients With Left Ventricular Support: LVAD Thrombosis

  • Ann B. Nguyen
  • Nir Uriel
  • Sirtaz AdatyaEmail author
Pathophysiology of Myocardial Failure (I Anand and M Patarroyo-Aponte, Section Editors)
Part of the following topical collections:
  1. Topical Collection on Pathophysiology of Myocardial Failure

Abstract

Mechanical circulatory support has revolutionized the treatment of heart failure, affording patients significantly improved survival and quality of life. However, further advancements in this technology have been hindered by adverse events, particularly gastrointestinal bleeding, driveline infection, stroke, and device thrombosis. Recently, there has been a renewed focus on device thrombosis as the reported incidence has increased. This review focuses on an update on the diagnostic modalities and current treatment algorithms of this serious complication.

Keywords

Device thrombosis Thrombolytics Echocardiographic ramp test Antifactor Xa 

Notes

Compliance with Ethical Standards

Conflict of Interest

Ann B. Nguyen, Nir Uriel, and Sirtaz Adatya declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

  1. 1.
    Kirklin JK, Naftel DC, Kormos RL, et al. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device. J Heart Lung Transplant. 2014;33:12–22.CrossRefPubMedGoogle Scholar
  2. 2.
    Netuka I, Sood P, Pya Y, et al. Fully magnetically levitated left ventricular assist system for treating advanced HF: a multicenter study. J Am Coll Cardiol. 2015;66:2579–89.CrossRefPubMedGoogle Scholar
  3. 3.
    Aaronson KD, Slaughter MS, Miller LW, et al. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation. 2012;125:3191–200.CrossRefPubMedGoogle Scholar
  4. 4.
    Starling RC, Moazami N, Silvestry SC, et al. Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med. 2014;370:33–40.CrossRefPubMedGoogle Scholar
  5. 5.
    Najjar SS, Slaughter MS, Pagani FD, et al. An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial. J Heart Lung Transplant. 2014;33:23–34.CrossRefPubMedGoogle Scholar
  6. 6.
    Stulak JM, Dunlay SM, Sharma S, et al. Treatment of device thrombus in the HeartWare HVAD: success and outcomes depend significantly on the initial treatment strategy. J Heart Lung Transplant. 2015;34:1535–41.CrossRefPubMedGoogle Scholar
  7. 7.
    Scandroglio AM, Kaufmann F, Pieri M, et al. Diagnosis and treatment algorithm for blood flow obstructions in patients with left ventricular assist device. J Am Coll Cardiol. 2016;67:2758–68.CrossRefPubMedGoogle Scholar
  8. 8.
    Dobarro D, Urban M, Booth K et al. Impact of aortic valve closure on adverse events and outcomes with the HeartWare ventricular assist device. J Heart Lung Transplant. 2016. doi: 10.1016/j.healun.2016.01.223.
  9. 9.
    Bagot CN, Arya R. Virchow and his triad: a question of attribution. Br J Haematol. 2008;143:180–90.CrossRefPubMedGoogle Scholar
  10. 10.
    Wu ZJ, Antaki JF, Burgreen GW, Butler KC, Thomas DC, Griffith BP. Fluid dynamic characterization of operating conditions for continuous flow blood pumps. ASAIO J. 1999;45:442–9.CrossRefPubMedGoogle Scholar
  11. 11.
    Sin DC, Kei HL, Miao X. Surface coatings for ventricular assist devices. Expert Rev Med Devices. 2009;6:51–60.CrossRefPubMedGoogle Scholar
  12. 12.
    Goldstein DJ, John R, Salerno C, et al. Algorithm for the diagnosis and management of suspected pump thrombus. J Heart Lung Transplant. 2013;32:667–70.CrossRefPubMedGoogle Scholar
  13. 13.
    Boyle AJ, Jorde UP, Sun B, et al. Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients. J Am Coll Cardiol. 2014;63:880–8.CrossRefPubMedGoogle Scholar
  14. 14.
    Koene RJ, Win S, Naksuk N, et al. HAS-BLED and CHA2DS2-VASc scores as predictors of bleeding and thrombotic risk after continuous-flow ventricular assist device implantation. J Card Fail. 2014;20:800–7.CrossRefPubMedGoogle Scholar
  15. 15.
    Kirklin JK, Naftel DC, Pagani FD, et al. Pump thrombosis in the Thoratec HeartMate II device: an update analysis of the INTERMACS registry. J Heart Lung Transplant. 2015;34:1515–26.CrossRefPubMedGoogle Scholar
  16. 16.
    Taghavi S, Ward C, Jayarajan SN, Gaughan J, Wilson LM, Mangi AA. Surgical technique influences HeartMate II left ventricular assist device thrombosis. Ann Thorac Surg. 2013;96:1259–65.CrossRefPubMedGoogle Scholar
  17. 17.
    Teuteberg JJ, Slaughter MS, Rogers JG, et al. The HVAD left ventricular assist device: risk factors for neurological events and risk mitigation strategies. JACC Heart Fail. 2015;3:818–28.CrossRefPubMedGoogle Scholar
  18. 18.
    Uriel N, Pak SW, Jorde UP, et al. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. J Am Coll Cardiol. 2010;56:1207–13.CrossRefPubMedGoogle Scholar
  19. 19.
    Letsou GV, Connelly JH, Delgado RM, et al. Is native aortic valve commissural fusion in patients with long-term left ventricular assist devices associated with clinically important aortic insufficiency? J Heart Lung Transplant. 2006;25:395–9.CrossRefPubMedGoogle Scholar
  20. 20.
    Emani S, Keebler M, Ransom J, et al. Prevention of HeartMate II pump thrombosis—recommendations and preliminary observations from the PREVENT study. Circulation. 2015;132:A16405.Google Scholar
  21. 21.
    Cowger JA, Romano MA, Shah P, et al. Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant. J Heart Lung Transplant. 2014;33:35–43.CrossRefPubMedGoogle Scholar
  22. 22.
    Shah P, Mehta VM, Cowger JA, Aaronson KD, Pagani FD. Diagnosis of hemolysis and device thrombosis with lactate dehydrogenase during left ventricular assist device support. J Heart Lung Transplant. 2014;33:102–4.CrossRefPubMedGoogle Scholar
  23. 23.
    Ravichandran AK, Parker J, Novak E, et al. Hemolysis in left ventricular assist device: a retrospective analysis of outcomes. J Heart Lung Transplant. 2014;33:44–50.CrossRefPubMedGoogle Scholar
  24. 24.
    Uriel N, Morrison KA, Garan AR, et al. Development of a novel echocardiography ramp test for speed optimization and diagnosis of device thrombosis in continuous-flow left ventricular assist devices: the Columbia ramp study. J Am Coll Cardiol. 2012;60:1764–75.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Uriel N, Han J, Morrison KA, et al. Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: a multifactorial phenomenon. J Heart Lung Transplant. 2014;33:51–9.CrossRefPubMedGoogle Scholar
  26. 26.
    Adatya S, Holley CT, Roy SS, et al. Echocardiographic ramp test for continuous-flow left ventricular assist devices: do loading conditions matter? JACC Heart Fail. 2015;3:291–9.CrossRefPubMedGoogle Scholar
  27. 27.
    Adatya S, Adataya S, Masri C, John R, Eckman P. Loading conditions influence reliability of the echocardiographic ramp test in continuous-flow left ventricular assist devices. J Heart Lung Transplant. 2013;32:1142–4.CrossRefPubMedGoogle Scholar
  28. 28.
    Fine NM, Topilsky Y, Oh JK, et al. Role of echocardiography in patients with intravascular hemolysis due to suspected continuous-flow LVAD thrombosis. JACC Cardiovasc Imaging. 2013;6:1129–40.CrossRefPubMedGoogle Scholar
  29. 29.
    Kaufmann F, Hörmandinger C, Stepanenko A, et al. Acoustic spectral analysis for determining pump thrombosis in rotary blood pumps. ASAIO J. 2014;60:502–7.CrossRefPubMedGoogle Scholar
  30. 30.
    Levin AP, Saeed O, Willey JZ et al. Watchful waiting in continuous-flow left ventricular assist device patients with ongoing hemolysis is associated with an increased risk for cerebrovascular accident or death. Circ Heart Fail. 2016;9:e002896.Google Scholar
  31. 31.
    Hasin T, Deo S, Maleszewski JJ, et al. The role of medical management for acute intravascular hemolysis in patients supported on axial flow LVAD. ASAIO J. 2014;60:9–14.CrossRefPubMedGoogle Scholar
  32. 32.
    Schlendorf K, Patel CB, Gehrig T, et al. Thrombolytic therapy for thrombosis of continuous flow ventricular assist devices. J Card Fail. 2014;20:91–7.CrossRefPubMedGoogle Scholar
  33. 33.
    Prasad SM, Robertson JO, Itoh A, Joseph SM, Silvestry SC. Histologic analysis of clots in explanted axial continuous-flow left ventricular assist devices. J Heart Lung Transplant. 2015;34:616–8.CrossRefPubMedGoogle Scholar
  34. 34.
    Levin AP, Uriel N, Takayama H, et al. Device exchange in HeartMate II recipients: long-term outcomes and risk of thrombosis recurrence. ASAIO J. 2015;61:144–9.CrossRefPubMedGoogle Scholar
  35. 35.
    Soleimani B, Stephenson ER, Price LC, El-Banayosy A, Pae WE. Clinical experience with sternotomy versus subcostal approach for exchange of HeartMate II left ventricular assist device. Ann Thorac Surg. 2015;100:1577–80.CrossRefPubMedGoogle Scholar
  36. 36.
    Jorde UP, Aaronson KD, Najjar SS, et al. Identification and management of pump thrombus in the HeartWare left ventricular assist device system: a novel approach using log file analysis. JACC Heart Fail. 2015;3:849–56.CrossRefPubMedGoogle Scholar
  37. 37.
    Adatya S, Uriel N, Yarmohammadi H, et al. Anti-factor Xa and activated partial thromboplastin time measurements for heparin monitoring in mechanical circulatory support. JACC Heart Fail. 2015;3:314–22.CrossRefPubMedGoogle Scholar
  38. 38.
    Adatya S, John R, Eckman PM. Treatment of hemolysis with intravenous unfractionated heparin using an antifactor Xa-based monitoring protocol. J Thorac Cardiovasc Surg. 2015;149:1465–6.CrossRefPubMedGoogle Scholar
  39. 39.
    Tellor BR, Smith JR, Prasad SM, Joseph SM, Silvestry SC. The use of eptifibatide for suspected pump thrombus or thrombosis in patients with left ventricular assist devices. J Heart Lung Transplant. 2014;33:94–101.CrossRefPubMedGoogle Scholar
  40. 40.
    Adatya S, Bennett MK. Anticoagulation management in mechanical circulatory support. J Thorac Dis. 2015;7:2129–38.PubMedPubMedCentralGoogle Scholar
  41. 41.
    Netuka I, Sood P, Pya Y, et al. Fully magnetically levitated left ventricular assist system for treating advanced HF: a multicenter study. J Am Coll Cardiol. 2015;66:2579–89.CrossRefPubMedGoogle Scholar
  42. 42.
    Aaronson KD, Slaughter MS, Miller LW, et al. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation. 2012;125:3191–200.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.Section of CardiologyUniversity of ChicagoChicagoUSA

Personalised recommendations